Video content material above is prompted by the next:
- How do you resolve between totally different therapy approaches, similar to bispecific antibodies (BCMA/GPRC5D), CAR T-cell remedy or different focused remedies?
- What are the variations in effectiveness, uncomfortable side effects and accessibility between these therapies?
